| abstract |
Compounds of formula (II) or their pharmaceutically acceptable salts or solvates are described: which are modulators of estrogen receptors. Pharmaceutical compositions of drugs are also described, which include the compounds described, as well as methods for using such estrogen receptor modulators, alone or in combination with other compounds, to treat diseases or conditions that are mediated by estrogen receptors or depend on estrogen receptors. |